Intellia Therapeutics to present at Morgan Stanley Global Healthcare conference
Intellia Therapeutics said it will present at the Morgan Stanley 24th Annual Global Healthcare Conference.
CAMBRIDGE, Mass., Sept.
04, 2026 (GLOBE NEWSWIRE) -- Intellia Therapeutics, Inc.
NASDAQ:NTLA, a leading biopharmaceutical company focused on revolutionizing medicine leveraging CRISPR gene editing and other core technologies, today announced that the company will present at the Morgan Stanley 24th…